PharmaCyte Biotech, Inc. (PMCB)
1.11
-0.04
(-3.48%)
USD |
NASDAQ |
Dec 09, 16:00
1.09
-0.02
(-1.80%)
After-Hours: 07:06
PharmaCyte Biotech Shareholders Equity (Quarterly): 43.59M for July 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Lunai Bioworks, Inc. | -13.04M |
| Kala Bio, Inc. | -8.665M |
| Femasys, Inc. | 4.556M |
| CEL-SCI Corp. | 7.025M |
| AIM ImmunoTech, Inc. | -6.077M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 45.11M |
| Total Liabilities (Quarterly) | 1.519M |
| Current Ratio | 18.01 |